Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New LDL-C Target Goal
REALISTIC: Protocol for an Observational Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New EAS LDL-C Target Goal
2 other identifiers
observational
2,650
1 country
75
Brief Summary
The purpose of this study is to determine the efficacy of Crestor in high risk patients switched from higher doses of other statins in obtaining the new European Atherosclerosis Society (EAS) low-density lipoprotein cholesterol (LDL-C) guidelines.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2004
Typical duration for all trials
75 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2004
CompletedFirst Submitted
Initial submission to the registry
October 16, 2005
CompletedFirst Posted
Study publicly available on registry
October 18, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2008
CompletedAugust 30, 2011
August 1, 2011
3.4 years
October 16, 2005
August 29, 2011
Conditions
Keywords
Eligibility Criteria
primary care
You may qualify if:
- High risk patients
- High doses of other statins
- LDL-C known, starts with Crestor 10 mg
- Permission to use patient data by AstraZeneca (AZ)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (75)
Research Site
's-Hertogenbosch, Netherlands
Research Site
Alkmaar, Netherlands
Research Site
Almelo, Netherlands
Research Site
Alphen aan den Rijn, Netherlands
Research Site
Amsterdam, Netherlands
Research Site
Apeldoorn, Netherlands
Research Site
Assen, Netherlands
Research Site
Bergen op Zoom, Netherlands
Research Site
Beverwijk, Netherlands
Research Site
Bilthoven, Netherlands
Research Site
Blaricum, Netherlands
Research Site
Boxmeer, Netherlands
Research Site
Breda, Netherlands
Research Site
Brunssum, Netherlands
Research Site
Capelle aan den IJssel, Netherlands
Research Site
Delft, Netherlands
Research Site
Delfzijl, Netherlands
Research Site
Den Helder, Netherlands
Research Site
Dirksland, Netherlands
Research Site
Doetinchem, Netherlands
Research Site
Dokkum, Netherlands
Research Site
Dordrecht, Netherlands
Research Site
Drachten, Netherlands
Research Site
Ede Gld, Netherlands
Research Site
Eindhoven, Netherlands
Research Site
Emmen, Netherlands
Research Site
Enschede, Netherlands
Research Site
Etten-Leur, Netherlands
Research Site
Flushing, Netherlands
Research Site
Geldrop, Netherlands
Research Site
Gouda, Netherlands
Research Site
Groningen, Netherlands
Research Site
Haarlem, Netherlands
Research Site
Hardenberg, Netherlands
Research Site
Heerenveen, Netherlands
Research Site
Heerlen, Netherlands
Research Site
Helmond, Netherlands
Research Site
Hengelo Ov, Netherlands
Research Site
Hoofddorp, Netherlands
Research Site
Hoogeveen, Netherlands
Research Site
Hoorn, Netherlands
Research Site
IJmuiden, Netherlands
Research Site
Landsmeer, Netherlands
Research Site
Leiden, Netherlands
Research Site
Lelystad, Netherlands
Research Site
Maastricht, Netherlands
Research Site
Meppel, Netherlands
Research Site
Oosterhout Nb, Netherlands
Research Site
Oss, Netherlands
Research Site
Purmerend, Netherlands
Research Site
Roermond, Netherlands
Research Site
Roosendaal, Netherlands
Research Site
Rotterdam, Netherlands
Research Site
Schiedam, Netherlands
Research Site
Sneek, Netherlands
Research Site
Spijkenisse, Netherlands
Research Site
Stadskanaal, Netherlands
Research Site
Terneuzen, Netherlands
Research Site
The Hague, Netherlands
Research Site
Tiel, Netherlands
Research Site
Tilburg, Netherlands
Research Site
Utrecht, Netherlands
Research Site
Veghel, Netherlands
Research Site
Veldhoven, Netherlands
Research Site
Venlo, Netherlands
Research Site
Vlaardingen, Netherlands
Research Site
Waalwijk, Netherlands
Research Site
Weert, Netherlands
Research Site
Winschoten, Netherlands
Research Site
Winterswijk, Netherlands
Research Site
Zaandam, Netherlands
Research Site
Zevenaar, Netherlands
Research Site
Zoetermeer, Netherlands
Research Site
Zutphen, Netherlands
Research Site
Zwolle, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
AstraZeneca Netherlands Medical Director, MD
AstraZeneca
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 16, 2005
First Posted
October 18, 2005
Study Start
September 1, 2004
Primary Completion
February 1, 2008
Study Completion
February 1, 2008
Last Updated
August 30, 2011
Record last verified: 2011-08